Great, thanks for your additions Matt, they are very useful. You've asked some great questions.
Yes the phrase optimising protocols could use some elaboration, I'll follow up when we have a few other questions to add.
I'm not sure that it is necessary to drill down on Richard's comment about the upcoming insomnia milestones. I believe he is just referring to the commercialisation of results adding value to the share price, as well as the other work they have in play in other areas?
Perhaps this thread is also a good place for questions to management to be collated, and then either Matt or I can submit them to Richard.
